Cargando…

Total Metabolic Tumor Volume on 18F-FDG PET/CT Is a Useful Prognostic Biomarker for Patients with Extensive Small-Cell Lung Cancer Undergoing First-Line Chemo-Immunotherapy

SIMPLE SUMMARY: Chemotherapy with immune checkpoint inhibitors is the new standard of care for first-line systemic therapy in extensive small-cell lung cancer. The identification of biomarkers for patients that are likely or not likely to respond to such therapy is critical. We aimed at determining...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grambow-Velilla, Julia, Seban, Romain-David, Chouahnia, Kader, Assié, Jean-Baptiste, Champion, Laurence, Girard, Nicolas, Bonardel, Gerald, Matton, Lise, Soussan, Michael, Chouaïd, Christos, Duchemann, Boris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136504/ https://www.ncbi.nlm.nih.gov/pubmed/37190152 http://dx.doi.org/10.3390/cancers15082223

Ejemplares similares

Association of the Metabolic Score Using Baseline FDG-PET/CT and dNLR with Immunotherapy Outcomes in Advanced NSCLC Patients Treated with First-Line Pembrolizumab
por: Seban, Romain-David, et al.
Publicado: (2020)

First-line immune-checkpoint inhibitor plus chemotherapy versus chemotherapy alone for extensive-stage small-cell lung cancer: a meta-analysis
por: Landre, Thierry, et al.
Publicado: (2020)

Monitoring anti-PD-1-based immunotherapy in non-small cell lung cancer with FDG PET: introduction of iPERCIST
por: Goldfarb, Lucas, et al.
Publicado: (2019)

Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18–18 and EGFR amplification: A case report
por: Wang, Pascal, et al.
Publicado: (2022)

18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer
por: Orlhac, Fanny, et al.
Publicado: (2015)

Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine
por: Seban, Romain-David, et al.
Publicado: (2021)

Outcome following nivolumab treatment in patients with advanced non-small cell lung cancer and comorbid interstitial lung disease in a real-world setting
por: Assié, Jean-Baptiste, et al.
Publicado: (2023)

Immune-Related Erythema Nodosum Mimicking in Transit Melanoma Metastasis on [18F]-FDG PET/CT
por: Seban, Romain-David, et al.
Publicado: (2021)

Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
por: Seban, Romain-David, et al.
Publicado: (2021)

(18)F-FDG PET/CT in Relapsed Endometrial Cancer Treated with Preoperative PD-1 Inhibitor Dostarlimab
por: Seban, Romain-David, et al.
Publicado: (2021)

Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer
por: Najid, Sophia, et al.
Publicado: (2023)

Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date
por: Bylicki, Olivier, et al.
Publicado: (2020)

Development, validation and clinical impact of a prediction model for 6-month mortality in older cancer patients: the GRADE
por: Angeli, Eurydice, et al.
Publicado: (2020)

Budget Impact Analysis of Fixed Dose Versus Weight-Based Dosing Regimen of Nivolumab and Pembrolizumab in the Treatment of Non-Small Cell Lung Cancer
por: Monirul, Sanjana, et al.
Publicado: (2020)

Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer: Systematic Literature Review and Meta-Analysis
por: Gendarme, Sébastien, et al.
Publicado: (2021)

Absolute Lymphocyte Count After COVID-19 Vaccination Is Associated with Vaccine-Induced Hypermetabolic Lymph Nodes on (18)F-FDG PET/CT: A Focus in Breast Cancer Care
por: Seban, Romain-David, et al.
Publicado: (2022)

Nivolumab treatment in advanced non-small cell lung cancer: real-world long-term outcomes within overall and special populations (the UNIVOC study)
por: Assié, Jean-Baptiste, et al.
Publicado: (2020)

Preliminary results in tracheal replacement using stented aortic matrices for primary extensive tracheal cancer
por: Onorati, Ilaria, et al.
Publicado: (2023)

Machine Learning–Based Analysis of Treatment Sequences Typology in Advanced Non–Small-Cell Lung Cancer Long-Term Survivors Treated With Nivolumab
por: Chouaïd, Christos, et al.
Publicado: (2022)

Clinical and phantom validation of a deep learning based denoising algorithm for F-18-FDG PET images from lower detection counting in comparison with the standard acquisition
por: Bonardel, Gerald, et al.
Publicado: (2022)

Determinants of malignant pleural mesothelioma survival and burden of disease in France: a national cohort analysis
por: Chouaid, Christos, et al.
Publicado: (2018)

Risk factors for early mortality of lung cancer patients in France: A nationwide analysis
por: Goussault, Hélène, et al.
Publicado: (2022)

Advances in PET/CT Imaging for Breast Cancer Patients and Beyond
por: Khalil, David, et al.
Publicado: (2023)

Timing and intensity of changes in FDG uptake with symptomatic esophagitis during radiotherapy or chemo-radiotherapy
por: Yuan, Shuanghu Tiger, et al.
Publicado: (2014)

To Chemo or Not to Chemo… That Is the Question
por: Martin, Maria Felisa Eva B., et al.
Publicado: (2023)

Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer
por: Vera, Pierre, et al.
Publicado: (2014)

Post–SARS-CoV-2 vaccination acute hemolysis in an older man: don’t forget to look at the blood smear
por: Duchemann, Boris, et al.
Publicado: (2021)

Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
por: Costantini, Adrien, et al.
Publicado: (2018)

Revisiting the identification of tumor sub-volumes predictive of residual uptake after (chemo)radiotherapy: influence of segmentation methods on (18)F-FDG PET/CT images
por: Hatt, Mathieu, et al.
Publicado: (2019)

The rim sign: FDG-PET/CT pattern of pulmonary infarction
por: Soussan, Michael, et al.
Publicado: (2012)

Hybrid Au@alendronate nanoparticles as dual chemo-photothermal agent for combined cancer treatment
por: Plan Sangnier, Anouchka, et al.
Publicado: (2018)

Influence of age on radiomic features in (18)F-FDG PET in normal breast tissue and in breast cancer tumors
por: Boughdad, Sarah, et al.
Publicado: (2018)

Infectious Bovine Respiratory Diseases in Adult Cattle: An Extensive Necropsic and Etiological Study
por: Dorso, Laëtitia, et al.
Publicado: (2021)

Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases
por: Chung, Yih-Lin, et al.
Publicado: (2016)

Extensive cardiac FDG uptake in a patient with AL amyloidosis
por: Hatipoglu, Suzan, et al.
Publicado: (2023)

Predictive value of initial FDG-PET features for treatment response and survival in esophageal cancer patients treated with chemo-radiation therapy using a random forest classifier
por: Desbordes, Paul, et al.
Publicado: (2017)

Impact of Physical Activity on Cancer-Specific and Overall Survival of Patients with Colorectal Cancer
por: Des Guetz, Gaetan, et al.
Publicado: (2013)

PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer
por: McGale, Jeremy, et al.
Publicado: (2023)

“From chemo to chemo”—the temporal paradox of chemotherapy
por: Moskalewicz, Marcin, et al.
Publicado: (2021)

Accuracy of Response Assessment FDG PET-CT Post (Chemo)Radiotherapy in HPV Negative Oropharynx Squamous Cell Carcinoma
por: Iyizoba-Ebozue, Zsuzsanna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmku4emsvg9pknlvgu59epa41t